PBI's 2008 Revenues Rise 32 Percent; Firm Set to Launch 'Important' Product in Q2 | GenomeWeb

Pressure BioSciences officials said this week that the firm remains on track to bring the its cash-burn rate to below $600,000 per quarter in 2009, following a restructuring of the business at the end of 2008.

The comments were made as PBI released its full-year 2008 financial results, which showed that PBI's total receipts increased 32 percent to $852,263 from $645,870 in 2007.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.